Table 4 Empirical antimicrobial therapy used for patients with solid malignancy and BSI
Empirical antibiotic therapy | Frequency | Percent (%) |
|---|---|---|
Initial regimen | ||
Monotherapy* | 33 | 28.4 |
Combination therapy* | 83 | 71.6 |
Aminoglycosides | 34 | 29.3 |
Cephalosporins | 18 | 15.5 |
Fluoroquinolones | 19 | 16.4 |
Carbapenems | 34 | 29.3 |
Macrolides | 2 | 1.7 |
Tetracyclines | 7 | 6 |
Piperacillin-tazobactam | 48 | 41.4 |
Trimethoprime-ulfamethoxazole | 1 | 0.9 |
Metronidazole | 5 | 4.3 |
Vancomycin | 45 | 38.8 |
Colistin | 8 | 6.9 |
Amoxicillin-clavulanic acid | 1 | 0.9 |
Antibiotics other than the mentioned above | 7 | 6 |
Anti-fungal drugs | 16 | 13.8 |